STAAR SURGICAL CO — Call Transcript 2022

Feb 24, 2022

U N IT E D S T A T ES

S E C U R IT I E S A N D E X CHA N GE CO M MISSION

WAS H IN G TON, DC 2 0549

FORM 8-K

CURRENT REPORT

P u r s u a n t t o S e c tion 13 or 15(d) of t h e S ec u r ities Excha n ge A c t of 1934

Da t e of re p o r t ( D a t e of e a r l i e st e v e n t r e p o r t e d) : February 23, 2022

STAAR Surgical Co mpany

( Ex act N a m e of Re g i s trant a s S p ecified i n Charter)

Delaware	0-11634	95-3797439
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)
25651 Atlantic Ocean Drive Lake Forest , California		92630
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s Telephone Number, Including Area Code: 626 - 303-7902

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Che c k t he a ppropr iate bo x b e l o w i f the F o r m 8 - K f il i n g is i n ten d ed to s i mult a ne o u sl y sati s f y t he f il i ng ob l i gati o n o f the r egistr a nt un d er a n y o f t he f o ll o w i n g pro visi o ns ( s ee G e ne r al I n s tructi o n A . 2 . b el o w ) :

☐	Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common	STAA	NASDAQ

I n dicate b y c h e c k m a r k w h e ther t h e re g i s tr a n t is a n e m er g i ng g r o w t h c o m pany as defi n ed in R u le 405 of t h e Se c u rities A ct o f 1 933 (17 C FR §230 . 405) or Ru le 1 2 b - 2 of t h e Se c u rities E x c han g e A ct of 1934 (17 C FR §240 . 1 2 b - 2).

E m e r g i n g g r o w t h c o m p a n y ☐

If an e m er g i ng g r o w th c o m p a n y , i n dicate b y c h e c k m ark i f t h e re g istra n t h as elected n ot to us e t h e e x t e n ded tra ns i t ion period f or co m p l y i n g w i th a ny n e w or re v i s ed f i n a n cial accou n t i ng s t a n da r ds pro v ided p u r su a n t to S ection 13(a) of t h e E x c h a n g e A ct. ☐

Item 7.01 Regulation FD Disclosure.

On February 23, 2022, the Company held a conference call to discuss the financial results for the quarter and fiscal year ended December 31, 2021. A transcript of the conference call is furnished as Exhibit 99.1 to this report and is incorporated herein by this reference.

The information furnished herewith pursuant to Item 7.01 of this Current Report, including Exhibit 99.1, shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information in Item 7.01 of this Current Report, and Exhibit 99.1, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report, regardless of any general incorporation language in the filing.

Item 9.01 Financial Statements and Exhibits

Exhibit No.	Description
99.1	Transcript of conference call of the Company held on February 23, 2022 .
104	Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

/s/ Caren Mason
Caren Mason
President and Chief Executive Officer